The California Life Sciences Association (CLSA) will host its “Afternoon with Thought Leaders” program in La Jolla, Calif. on July 28, 2016 and convene an important discussion on Pandemic Preparedness: The Public-Private Research and Response Infrastructure.
In addition to a live stream keynote from Dr. Thomas R. Frieden, Director, Centers for Disease Control and Prevention (CDC), four leading health experts will join CLSA to discuss how effective and timely responses to emergent public health crises and pandemic threats – Ebola, H1N1, SARS, Zika, etc. – require a united approach by public health agencies, non-profits, healthcare companies and other important stakeholders.
This CLSA event will examine these critical partnerships, how our nation’s pandemic preparedness and response infrastructure functions, and how it can be improved.
Penny Heaton, M.D., Director of Vaccine Development, Bill and Melinda Gates Foundation will serve as the moderator. Noted panelists include:
- David Ecker, Ph.D., Divisional Vice President, Carlsbad Site General Manager, Abbott
- Rekha Murthy, M.D., Vice President, Medical Affairs, Associate Chief Medical Officer, Professor of Medicine, Cedars-Sinai Medical Center
- Quita Highsmith, Franchise Head, Tamiflu, Genentech
- Bill Lee, Ph.D., Executive Vice President, Research, Gilead Sciences
California Life Sciences Association (CLSA) was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization. CLSA works closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem.
